Literature DB >> 16362650

Migraine with aura, bipolar depression, ACM aneurysm. A case report.

Sergio de Filippis1, Emiliano Salvatori, Alessandro Bozzao, Luigi Maria Fantozzi, Paolo Martelletti.   

Abstract

B.D. is a 48-year-old professional woman. She has been suffering for migraine since she was 28, but she did not have serious problems until last year, when headache episodes became more frequent and it was necessary an admission to emergency room. At the beginning, the events were about 6 per month, lasting from 2 to 4 days, beating and of high intensity together with nausea, vomit, photo and phonophobia and visual area. Looking at the anamnesis, we report a psychiatric treatment since about ten years, because of type II bipolar disorder. In spite of the psychopharmacological treatment, as the patient came in our Regional Headache Center, she talked about 7 events with aura (scintillating scotomas, emianopsia) per month, lasting 2-4 days with photo and phonophobia, nausea, crying crisis, anxiety. Although the neurological examination was normal, the sudden aggravation of pain symptomatology and the unresposiveness to usual painkillers, suggested a cerebral CT and CT-angiography. CT and CT-angiography discovered the presence of an aneurysm of the right middle cerebral artery (MCA) of 4 mm diameter, with parietal irregularities. The patient was operated to reduce the hemorrhagic risk, with a positive result. One year after the operation, the patient reports a decrease of headache events with a frequency of 2 per month, lasting only a few hours, which she can now solve with COXIB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362650      PMCID: PMC3452315          DOI: 10.1007/s10194-005-0159-0

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  1 in total

1.  Migraine before rupture of intracranial aneurysms.

Authors:  Elena R Lebedeva; Natalia M Gurary; Vladimir P Sakovich; Jes Olesen
Journal:  J Headache Pain       Date:  2013-02-20       Impact factor: 7.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.